These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10915132)

  • 1. A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs.
    Avery AJ; Rodgers S; Heron T; Crombie R; Whynes D; Pringle M; Baines D; Petchey R
    BMJ; 2000 Jul; 321(7256):276-81. PubMed ID: 10915132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence into practice. Prescribing selective serotonin reuptake inhibitors.
    Freemantle N; Mason JM; Watt I
    Int J Technol Assess Health Care; 1998; 14(2):387-91. PubMed ID: 9611911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.
    Hurley MP; Stafford RS; Lane AT
    JAMA Dermatol; 2014 May; 150(5):487-93. PubMed ID: 24740450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundholders' prescribing costs: the first five years.
    Harris CM; Scrivener G
    BMJ; 1996 Dec; 313(7071):1531-4. PubMed ID: 8978232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study.
    Rafferty T; Wilson-Davis K; McGavock H
    BMJ; 1997 Jul; 315(7101):166-70. PubMed ID: 9251548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England.
    Roberts SJ; Harris CM
    BMJ; 1993 Aug; 307(6902):485-8. PubMed ID: 8305014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines.
    Roberts SJ; Bateman DN; Smith JM
    Br J Gen Pract; 1997 Jan; 47(414):13-8. PubMed ID: 9115786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis.
    Fleetcroft R; Cookson R; Steel N; Howe A
    Br J Gen Pract; 2011 Sep; 61(590):e556-64. PubMed ID: 22152735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing costs in dispensing practices.
    Morton-Jones TJ; Pringle MA
    BMJ; 1993 May; 306(6887):1244-6. PubMed ID: 8499855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drug sample removal on prescribing in a family practice clinic.
    Hartung DM; Evans D; Haxby DG; Kraemer DF; Andeen G; Fagnan LJ
    Ann Fam Med; 2010; 8(5):402-9. PubMed ID: 20843881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care.
    Croker R; Smyth D; Walker AJ; Goldacre B
    BMJ Open; 2018 Jun; 8(6):e022416. PubMed ID: 29880577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
    Bradlow J; Coulter A
    BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme.
    Stewart-Brown S; Surender R; Bradlow J; Coulter A; Doll H
    BMJ; 1995 Dec; 311(7019):1543-7. PubMed ID: 8520399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders.
    Wilson RP; Hatcher J; Barton S; Walley T
    Br J Gen Pract; 1999 Jun; 49(443):431-5. PubMed ID: 10562740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in prescribing by general practitioner fundholders: an observational study.
    Wilson RP; Buchan I; Walley T
    BMJ; 1995 Nov; 311(7016):1347-50. PubMed ID: 7496289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.